TAIPEI, Taiwan, Sept. 19, 2016 /PRNewswire/ -- Medeon Biodesign, Inc., a Taiwan medical device company, announces today that the company has received U.S. Food and Drug Administration 510(k) clearance for AbClose™, a single use, disposable laparoscopic port site closure device. AbClose™ is a revolutionary advancement in port site closure technology that enables fast, simple, and secure single-operator suturing and eliminates the majority of user variability.